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Abstract
©  the  Partner  Organisations  2014.  Novel  pyrimidinophanes  possessing  two  o-
nitrobenzylethyldialkylammonium  heads  bridging  with  different  spacers  were  prepared.
Pyrimidinophanes 2a, 2b and 3 are reversible inhibitors of cholinesterases. They show a very
good selectivity for human acetylcholinesterase (AChE), with an inhibitory power 100-200 times
higher  than  for  human  butyrylcholinesterase  (BChE).  Docking  simulations  indicate  specific
binding  of  pyrimidinophanes  2a  and  4  onto  the  peripheral  anionic  site  of  AChE.  Other
compounds bind to the active center of AChE as well as to the peripheral anionic site. These
compounds are dual binding site inhibitors. Pyrimidinophane 2b and its acyclic counterpart 1
were tested in the animal model of myasthenia gravis and may be considered as valuable
candidates for the treatment of pathological muscle weakness syndromes. This journal is
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